Mortalidad durante la pandemia de COVID-19 en una población de adultos mayores y su asociación con diabetes tipo 2
Severe acute respiratory syndrome by coronavirus-2019 (COVID-19), affected 550 million people worldwide and caused more than 6 million deaths. Older adults (OA) were the most affected population segment in terms of hospitalization, poor outcomes, and mortality from COVID-19. This results from the hi...
Guardado en:
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Artículo revista |
| Publicado: |
Universidad Nacional Córdoba. Facultad de Ciencias Médicas. Secretaria de Ciencia y Tecnología
2022
|
| Materias: | |
| Acceso en línea: | https://revistas.unc.edu.ar/index.php/med/article/view/39050 |
| Aporte de: |
| Sumario: | Severe acute respiratory syndrome by coronavirus-2019 (COVID-19), affected 550 million people worldwide and caused more than 6 million deaths. Older adults (OA) were the most affected population segment in terms of hospitalization, poor outcomes, and mortality from COVID-19. This results from the high prevalence of comorbidities in OA. Type 2 diabetes also has a high prevalence in this age group and the susceptibility, severity, and mortality from COVID-19 among diabetic patients is increased. This background led us to investigate the impact of COVID-19 on a local population of OA with diabetes. Objective: To determine mortality rates during pre-pandemic periods (years 2018-2019) and COVID-19 pandemic (2020-2021) in the studied population of OA and calculate excess mortality. To determine if diabetic patients had an increased mortality risk in this population.
Retrospective study of medical records of 658 elderly patients, average age 76 years, treated at the "San Ricardo Pampuri" Health Center in Villa Carlos Paz (Córdoba, Argentina), between 2018 and 2022. The results were statistically analyzed. data using Infostat (α=0.05). The main epidemiological measures were calculated, the Odd Ratio was determined for diabetic patients and values were compared between periods.
Mortality rates during the periods evaluated were 2018-2019: 6.23% and 2020-2021: 8.75%. Among diabetic patients, mortality was: 2018-2019: 9.46% vs 2020-2021: 13.81%. COVID-19-specific mortalities were 2018-2019: 0%, in 2020-2021: 3.08% overall and 5.22% among diabetic patients. During the pandemic, mortality increased by 40% in this OA population. Diabetic patients had a higher risk (OR: 2.6) of dying from COVID-19. The partial data for 2022 indicate that mortality decreased compared to the same period in 2021 (11 vs 19 total deaths and 2 vs 7 due to COVID-19, respectively).
During the COVID-19 pandemic, an increase in mortality was observed in the OA population studied, with a greater impact on patients with diabetes. The downward trend in these indicators in 2022 can probably be explained by the vaccination of this population against SARS-COV-2. |
|---|